Profile data is unavailable for this security.
About the company
Medacta Group SA is a Swiss-based company specialized in medical devices. The Company is specialized in the design, production and distribution of orthopedic products and the development of accompanying surgical techniques for joint replacement, spine surgery, and sports medicine. The Company designs a number of products, such as hip products, including hip replacement, hip anatomy, hip diseases, and other products for the preparation of hip surgery; knee product, which encompasses knee anatomy, knee diseases, knee replacement, the stability of the knee and for the preparation of knee surgery; shoulder product, which includes shoulder anatomy, shoulder disease, shoulder replacement, and for the preparation of shoulder operation, and spine product, which includes products for spinal treatments, spinal anatomy and for surgery, among others. Additionally, the Company also offers training and support to healthcare professionals.
- Revenue in CHF (TTM)588.97m
- Net income in CHF86.54m
- Incorporated2018
- Employees2.04k
- LocationMedacta Group SAStrada Regina 34CASTEL SAN PIETRO 6874SwitzerlandCHE
- Websitehttps://www.medacta.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Embla Medical hf | 714.64m | 64.13m | 1.59bn | 4.19k | 24.67 | 2.31 | 14.36 | 2.23 | 1.23 | 1.23 | 13.69 | 13.12 | 0.5681 | 2.27 | 6.96 | 1,396,314.00 | 5.12 | 4.60 | 6.10 | 5.43 | 62.30 | 62.25 | 9.01 | 7.99 | 0.9445 | 7.22 | 0.3768 | 0.00 | 8.63 | 8.09 | 22.05 | 68.07 | 6.12 | -- |
| Elekta AB (publ) | 1.51bn | 25.11m | 1.72bn | 4.48k | 71.14 | 2.46 | 12.71 | 1.14 | 0.7646 | 0.7646 | 45.97 | 22.11 | 0.5781 | 3.35 | 3.09 | 3,872,796.00 | 0.9511 | 3.48 | 1.70 | 6.21 | 38.17 | 38.22 | 1.65 | 6.02 | 0.7918 | 7.51 | 0.4724 | 92.20 | -0.5685 | 4.29 | -81.80 | -26.22 | 15.56 | 5.92 |
| SCHOTT Pharma AG & Co KgaA | 908.91m | 137.48m | 2.06bn | 4.81k | 14.98 | 2.43 | 9.46 | 2.27 | 1.00 | 1.00 | 6.63 | 6.18 | 0.6414 | 3.95 | 3.98 | 207,141.30 | 9.74 | 11.86 | 13.61 | 16.87 | 33.68 | 34.65 | 15.18 | 15.68 | 1.17 | -- | 0.0824 | 10.95 | 3.04 | 11.04 | -2.16 | 13.58 | 11.15 | -- |
| Carl Zeiss Meditec AG | 2.01bn | 110.01m | 2.11bn | 5.78k | 18.80 | -- | -- | 1.05 | 1.37 | 1.37 | 25.58 | -- | -- | -- | -- | 381,084.40 | -- | 8.00 | -- | 9.78 | 52.19 | 56.02 | 5.53 | 11.56 | -- | 7.38 | -- | 33.14 | 7.82 | 10.78 | -20.99 | 2.90 | 11.23 | 1.92 |
| Asker Healthcare Group AB | 1.44bn | 42.32m | 2.11bn | 4.58k | 48.20 | -- | 18.46 | 1.46 | 1.33 | 1.33 | 45.59 | -- | 1.12 | 5.14 | 8.48 | 3,665,284.00 | 3.41 | -- | 4.52 | -- | 40.92 | -- | 3.04 | -- | 0.8497 | 3.20 | 0.4688 | -- | 11.73 | -- | 36.67 | -- | -- | -- |
| Ambu A/S | 742.92m | 66.42m | 2.35bn | 5.43k | 39.99 | 3.61 | 20.81 | 3.16 | 2.04 | 2.04 | 22.85 | 22.64 | 0.8135 | 1.95 | 7.18 | 1,130,201.00 | 7.27 | 4.06 | 8.49 | 4.82 | 60.07 | 59.33 | 8.94 | 5.48 | 1.67 | 20.74 | 0.0845 | 21.23 | 11.98 | 11.10 | 159.15 | 20.37 | -2.24 | 7.17 |
| Sectra AB | 192.43m | 55.59m | 2.76bn | 1.32k | 52.48 | 18.97 | 42.15 | 14.33 | 3.36 | 3.36 | 11.62 | 9.29 | 0.6688 | -- | 3.93 | 1,726,353.00 | 19.32 | 15.75 | 35.74 | 29.92 | 54.43 | 60.29 | 28.89 | 22.41 | -- | -- | 0.0505 | 19.27 | 19.85 | 4.47 | 31.51 | 18.87 | 7.19 | -- |
| Amplifon SpA | 2.20bn | 105.45m | 2.79bn | 15.07k | 26.31 | 3.07 | 7.10 | 1.27 | 0.5144 | 0.5144 | 10.76 | 4.41 | 0.6234 | 20.42 | 10.46 | 159,803.00 | 3.00 | 4.21 | 4.36 | 5.78 | 22.49 | 61.07 | 4.81 | 7.16 | 0.5413 | 3.86 | 0.6612 | 41.46 | 6.60 | 6.82 | -6.29 | 5.99 | 9.95 | -- |
| Medacta Group SA | 588.97m | 86.54m | 2.96bn | 2.04k | 34.09 | 7.62 | 19.70 | 5.02 | 4.34 | 4.34 | 29.51 | 19.41 | 0.8113 | 0.853 | 5.83 | 308,847.80 | 11.92 | 9.07 | 15.29 | 11.84 | 67.55 | 69.31 | 14.69 | 11.57 | 0.9472 | 10.51 | 0.3751 | 18.68 | 15.62 | 13.71 | 53.89 | 43.79 | 15.22 | -- |
| Ottobock SE & Co KgaA | 1.50bn | 52.81m | 3.38bn | -- | 63.93 | 16.17 | 19.43 | 2.25 | 0.9048 | 0.9048 | 25.67 | 3.58 | -- | -- | -- | -- | -- | -- | -- | -- | 52.42 | -- | 3.42 | -- | 0.6458 | 3.18 | 0.8358 | -- | 7.33 | -- | -38.37 | -- | -- | -- |
| DiaSorin SpA | -91.21bn | -91.21bn | 3.66bn | 3.28k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 8.62 | -- | 9.57 | -- | 66.24 | -- | 19.69 | -- | -- | -- | 25.25 | 3.24 | 10.91 | 17.68 | 1.37 | 16.50 | 4.78 |
| Ypsomed Holding AG | 787.55m | 194.00m | 4.08bn | 2.00k | 21.01 | 5.05 | 14.94 | 5.19 | 14.21 | 14.21 | 57.70 | 59.14 | 0.6591 | 6.14 | 5.78 | 297,862.70 | 16.24 | 5.55 | 23.88 | 8.67 | 41.25 | 32.32 | 24.63 | 9.24 | 1.19 | 27.75 | 0.1199 | 19.78 | 36.54 | 13.69 | 11.66 | 49.46 | 18.48 | 61.54 |
| Getinge AB | 3.01bn | 194.20m | 4.32bn | 11.79k | 23.84 | 1.83 | 11.52 | 1.44 | 8.29 | 8.29 | 128.39 | 108.05 | 0.5808 | 2.91 | 5.36 | -- | 3.78 | 4.48 | 4.94 | 5.91 | 47.63 | 47.54 | 6.51 | 7.57 | 0.8595 | 7.05 | 0.2696 | 47.51 | 0.6042 | 3.24 | 37.85 | -6.96 | 4.69 | 9.63 |
Data as of Feb 17 2026. Currency figures normalised to Medacta Group SA's reporting currency: Swiss Franc CHF
10.54%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Artisan Partners LPas of 16 Dec 2025 | 598.00k | 2.99% |
| UBS Asset Management Switzerland AGas of 03 Feb 2026 | 342.50k | 1.71% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 232.31k | 1.16% |
| GAM Investment Management (Switzerland) AGas of 31 Mar 2025 | 208.84k | 1.04% |
| Juno Investment Partners BVas of 30 Sep 2025 | 148.79k | 0.74% |
| Entrepreneur Partners AGas of 30 Jun 2025 | 139.00k | 0.70% |
| Norges Bank Investment Managementas of 30 Jun 2025 | 136.59k | 0.68% |
| State Board of Administration of Florida Retirement Systemas of 30 Sep 2025 | 111.95k | 0.56% |
| SEB Investment Management AB (Denmark)as of 30 Jan 2026 | 100.20k | 0.50% |
| Z�rcher Kantonalbank (Investment Management)as of 30 Jan 2026 | 88.98k | 0.45% |
More ▼
Data from 30 Jun 2025 - 30 Jan 2026Source: FactSet Research Systems Inc.
